(NASDAQ: THRD) Third Harmonic Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.96%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.59%.
Third Harmonic Bio's earnings in 2025 is -$45,469,000.On average, 3 Wall Street analysts forecast THRD's earnings for 2025 to be -$41,644,430, with the lowest THRD earnings forecast at -$43,299,743, and the highest THRD earnings forecast at -$38,789,353. On average, 3 Wall Street analysts forecast THRD's earnings for 2026 to be -$42,546,508, with the lowest THRD earnings forecast at -$45,554,938, and the highest THRD earnings forecast at -$39,691,431.
In 2027, THRD is forecast to generate -$48,112,329 in earnings, with the lowest earnings forecast at -$64,047,537 and the highest earnings forecast at -$36,083,119.